Immunovia AB (OTCPK:IMMVF)
$ 0.07382 0 (0%) Market Cap: 9.92 Mil Enterprise Value: 7.11 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 44/100

Immunovia AB (publ) - Special Call Transcript

Apr 01, 2020 / 02:30PM GMT
Release Date Price: $8.93
Operator

Hello, and welcome to the Immunovia presentation. My name is Val, and I will be your coordinator for today's event. Please note this conference is being recorded. (Operator Instructions) I will now hand you over to your host, Mats Grahn, CEO of Immunovia, to begin today's conference. Thank you.

Mats Grahn;publ;CEO
Immunovia AB

()-

Yes. Hello, everyone, and welcome to this call and conference where we will discuss the -- and to make an update how we handle the COVID-19 pandemic at Immunovia. And these days, we are all affected one way or another, and I hope you all listening are well and thanks for joining us today.

So far, I would say, in general, we have been handling this very well, and we are in good shape moving forward. And we will look into the different aspects where we have worked to mitigate the impact of COVID-19.

As you will see on the slides, the ones of you who are there now should have our agenda in front of you. There are 4 areas I will cover today. We'll talk about the response to COVID-19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot